2NEWCOMER JW. Abnormalities of glucose metabolism associated with atypical antipsychotic drugs[ J ]. J Clin Psychiatry, 2004,659 (Suppl 18) :36-46.
3JIA WP, XIANG KS, CHEN L, et al. Epidemiological study on obesity and its comorbidities in urban Chinese older than 20 years of age in Shanghai,China[J]. Obes Rev,2002,3(3) : 157-165.
4FORD ES, GILF.S WH, DIETZ WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey[J]. JAMA, 2002,287 (3) :356-359.
5RESNICK HE,Strong Heart Study Investigators. Metabolic syndrome in American Indians[J ]. Diabetes Care,2002,25(7) : 1246- 1247.
6DEFRONZO RA, FERRANNINI E. INSULIN RESISTANCE. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidirmia, and atherosclerotic cardiovascular disease [J ]. Diabetes Care, 1991,14(3) : 173-194.
7Jia WP, Xiang KS, Chen L, et al. Epidemiological study on obesity and its comorbidities in urban Chinese older than 20 years of age in Shanghai, China[J]. Obes Rev, 2002, 3 (3): 157-165.
8Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey[J]. JAMA, 2002, 287 (3): 356-359.
9Resnick HE, Strong Heart Study Investigators. Metabolic syndrome in American Indians[J]. Diabetes Care, 2002, 25 (7): 1246-1247.
10DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease[J]. Diabetes Care, 1991, 14(3): 173-194.
